Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Manag Care Spec Pharm ; 30(1-a Suppl): S1-S15, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-38190244

RESUMO

Diabetes is a complex chronic condition that affects the body's ability to produce or use insulin effectively, resulting in elevated blood glucose levels. It is associated with various complications and comorbidities, significantly impacting both individuals and the health care system. Effective management involves a combination of lifestyle adjustments, medication adherence, monitoring, education, and support. The expanding use of continuous glucose monitoring (CGM) has been transformative in diabetes care, providing valuable real-time data and insights for better management. To understand the opportunity for health plans to support improved patient outcomes with CGM, AMCP sponsored a multifaceted approach to identify best practices consisting of expert interviews, a national payer survey, an expert panel workshop with clinical experts and managed care stakeholders, and a national webcast to communicate the program findings. This article summarizes current evidence for CGM to support managed care and payer professionals in making collaborative, evidence-based decisions to optimize outcomes among patients with diabetes. In addition, this review also presents the findings of a national payer survey and describes expert-supported health plan best practices around coverage and access to CGM.


Assuntos
Monitoramento Contínuo da Glicose , Diabetes Mellitus , Humanos , Glicemia , Automonitorização da Glicemia , Diabetes Mellitus/tratamento farmacológico , Tomada de Decisões
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...